{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:49:11Z","timestamp":1778615351336,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jad.2022.07.073","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:04:44Z","timestamp":1659524684000},"page":"156-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Clinical course and serum amyloid \u03b2 levels in elderly patients with major depressive disorder"],"prefix":"10.1016","volume":"315","author":[{"given":"Shuntaro","family":"Natsume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takao","family":"Saida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Yoshinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihito","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2022.07.073_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4088\/JCP.10m06766","article-title":"Metabolism of amyloid-beta protein may be affected in depression","volume":"73","author":"Baba","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2022.07.073_bb0010","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/pcn.13349","article-title":"Guidelines for diagnosis and treatment of depression in older adults: a report from the Japanese Society of Mood Disorders","volume":"76","author":"Baba","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.jad.2022.07.073_bb0015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","article-title":"Frequency of stages of alzheimer-related lesions in different age categories","volume":"18","author":"Braak","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.jad.2022.07.073_bb0020","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"6","key":"10.1016\/j.jad.2022.07.073_bb0025","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.jad.2022.07.073_bb0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1192\/bjp.bp.111.101931","article-title":"Affective disorders and risk of developing dementia: systematic review","volume":"202","author":"da Silva","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.07.073_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1192\/bjp.bp.112.118307","article-title":"Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies","volume":"202","author":"Diniz","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2022.07.073_bb0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1212\/01.wnl.0000278386.00035.21","article-title":"Plasma amyloid beta protein is elevated in late-onset Alzheimer disease families","volume":"70","author":"Ertekin-Taner","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jad.2022.07.073_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0009-8981(85)90269-4","article-title":"A rapid flat gel isoelectric focusing method for the determination of apolipoprotein E phenotypes and its application","volume":"149","author":"Eto","year":"1985","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.jad.2022.07.073_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2022.07.073_bb0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archpsyc.1991.01810330075011","article-title":"Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence","volume":"48","author":"Frank","year":"1991","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.jad.2022.07.073_bb0060","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1001\/archneur.60.7.958","article-title":"Age but not diagnosis is the main predictor of plasma amyloid \u03b2-protein levels","volume":"60","author":"Fukumoto","year":"2003","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jad.2022.07.073_bb0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2007.09.023","article-title":"The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease","volume":"427","author":"Giedraitis","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.jad.2022.07.073_bb0070","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/archneur.64.3.354","article-title":"Association of low plasma Abeta42\/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease","volume":"64","author":"Graff-Radford","year":"2007","journal-title":"Arch. Neurol."},{"issue":"35","key":"10.1016\/j.jad.2022.07.073_bb0075","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1523\/JNEUROSCI.2797-06.2006","article-title":"Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease","volume":"26","author":"Green","year":"2006","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.jad.2022.07.073_bb0080","first-page":"1443","article-title":"Dose equivalence of psychotropic drugs","volume":"9","author":"Inagaki","year":"2006","journal-title":"Jpn. J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.jad.2022.07.073_bb0085","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1001\/archpsyc.65.8.906","article-title":"Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia aging study","volume":"65","author":"Irie","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.073_bb0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.psychres.2017.10.008","article-title":"Glucocorticoid may influence amyloid beta metabolism in patients with depression","volume":"259","author":"Ishijima","year":"2018","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.jad.2022.07.073_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of a beta 42(43) and a beta 40 in senile plaques with end-specific a beta monoclonals: evidence that an initially deposited species is a beta 42(43)","volume":"13","author":"Iwatsubo","year":"1994","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.jad.2022.07.073_bb0100","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid \u03b2 protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.jad.2022.07.073_bb0105","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.euroneuro.2016.11.004","article-title":"Electroconvulsive therapy selectively enhances amyloid beta 1\u201342 in the cerebrospinal fluid of patients with major depression: a prospective pilot study","volume":"26","author":"Kranaster","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.jad.2022.07.073_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jnen\/64.2.139","article-title":"Effects of chronic glucocorticoid administration on insulin-degrading enzyme and amyloid-beta peptide in the aged macaque","volume":"64","author":"Kulstad","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"11","key":"10.1016\/j.jad.2022.07.073_bb0115","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1212\/WNL.0b013e3181b78448","article-title":"Association of plasma amyloid beta with risk of dementia: the prospective Three-City study","volume":"73","author":"Lambert","year":"2009","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.jad.2022.07.073_bb0120","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuint.2009.08.006","article-title":"No correlation between time-linked plasma and CSF abeta levels","volume":"55","author":"Le Bastard","year":"2009","journal-title":"Neurochem. Int."},{"issue":"19","key":"10.1016\/j.jad.2022.07.073_bb0125","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1212\/01.wnl.0000306696.82017.66","article-title":"Plasma amyloid levels and the risk of AD in normal subjects in the cardiovascular health study","volume":"70","author":"Lopez","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jad.2022.07.073_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A","article-title":"Plasma amyloid \u03b2-peptide 1\u201342 and incipient Alzheimer's disease","volume":"46","author":"Mayeux","year":"1999","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.jad.2022.07.073_bb0135","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.jad.2022.07.073_bb0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0304-3940(01)01754-2","article-title":"Amyloid beta protein 1\u201340 and 1\u201342 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease","volume":"304","author":"Mehta","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jad.2022.07.073_bb0145","series-title":"Japanese Version of Structured Interview Guide for the Hamilton Depression Rating Scale (SIGH-D)","author":"Nakane","year":"2004"},{"key":"10.1016\/j.jad.2022.07.073_bb0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.pnpbp.2012.12.016","article-title":"Heterogeneity of elderly depression: increased risk of Alzheimer's disease and abeta protein metabolism","volume":"43","author":"Namekawa","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2022.07.073_bb0155","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpsychires.2015.07.024","article-title":"Plasma and cerebrospinal fluid amyloid-\u03b2 levels in late-life depression: a systematic review and meta-analysis","volume":"69","author":"Nascimento","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.jad.2022.07.073_bb0160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.63.5.530","article-title":"Depression and risk for alzheimer disease: systematic review, meta-analysis, and metaregression analysis","volume":"63","author":"Ownby","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2022.07.073_bb1000","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.3390\/brainsci11101352","article-title":"Mental illness and amyloid: a scoping review of scientific evidence over the last 10 years (2011 to 2021)","volume":"11","author":"Pandolfo","year":"2021","journal-title":"Brain Sci."},{"issue":"3","key":"10.1016\/j.jad.2022.07.073_bb0165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11064-005-9029-z","article-title":"Elevation in plasma Abeta42 in geriatric depression: a pilot study","volume":"31","author":"Pomara","year":"2006","journal-title":"Neurochem. Res."},{"issue":"5","key":"10.1016\/j.jad.2022.07.073_bb0170","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1176\/appi.ajp.2011.11081153","article-title":"Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder","volume":"169","author":"Pomara","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"14","key":"10.1016\/j.jad.2022.07.073_bb0175","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/WNR.0000000000000658","article-title":"State-dependent alterations in cerebrospinal fluid A\u03b242 levels in cognitively intact elderly with late-life major depression","volume":"27","author":"Pomara","year":"2016","journal-title":"Neuroreport."},{"issue":"2","key":"10.1016\/j.jad.2022.07.073_bb0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.63.2.161","article-title":"Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression","volume":"63","author":"Rapp","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2022.07.073_bb0185","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.mp.4000313","article-title":"Cerebral changes and cerebrospinal fluid beta-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imaging","volume":"2","author":"Schroder","year":"1997","journal-title":"Mol. Psychiatry"},{"issue":"37","key":"10.1016\/j.jad.2022.07.073_bb0190","doi-asserted-by":"crossref","first-page":"14052","DOI":"10.1073\/pnas.0805902105","article-title":"Peripheral abeta subspecies as risk biomarkers of Alzheimer's disease","volume":"105","author":"Schupf","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.jad.2022.07.073_bb0195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jamapsychiatry.2017.0660","article-title":"Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study","volume":"74","author":"Singh-Manoux","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2022.07.073_bb0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2005-1544","article-title":"Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease","volume":"65","author":"Sobow","year":"2005","journal-title":"Acta Neurobiol. Exp. (Wars.)"},{"issue":"12","key":"10.1016\/j.jad.2022.07.073_bb0205","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.biopsych.2007.01.003","article-title":"Depression, antidepressants, and plasma amyloid beta (Beta) peptides in those elderly who do not have cardiovascular disease","volume":"62","author":"Sun","year":"2007","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2022.07.073_bb0210","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archpsyc.65.5.542","article-title":"Amyloid-associated depression: a prodromal depression of Alzheimer disease?","volume":"65","author":"Sun","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.jad.2022.07.073_bb0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1474-4422(06)70501-4","article-title":"Plasma Abeta(1\u201340) and Abeta(1\u201342) and the risk of dementia: a prospective case-cohort study","volume":"5","author":"van Oijen","year":"2006","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jad.2022.07.073_bb0220","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/ggi.13826","article-title":"Serum levels and mutual correlations of amyloid \u03b2 in patients with depression","volume":"20","author":"Yasuda","year":"2020","journal-title":"Geriatr. Gerontol. Int."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722008412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032722008412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T03:22:49Z","timestamp":1759029769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032722008412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":45,"alternative-id":["S0165032722008412"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.07.073","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical course and serum amyloid \u03b2 levels in elderly patients with major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.07.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}